Advertisement
News
Subscribe to MDT Magazine News

GeoResources, Prospect Capital to join S & P index

February 15, 2011 11:45 am | by The Associated Press | Comments

GeoResources Inc. and Prospect Capital Corp. will be added to the S&P SmallCap 600 index, according to Standard & Poor's, sending shares of both companies higher Tuesday.S&P announced the planned index changes following Monday's close of trading. Stocks that are about to be added to indexes...

Cynosure narrows 4Q loss, as revenue climbs 16 pct

February 15, 2011 10:45 am | by The Associated Press | Comments

Cynosure Inc., the cosmetic treatment equipment maker, reported a smaller loss for the fourth quarter on Tuesday, helped by growing revenue and a drop in operating expenses. Its shares rose 15 percent in afternoon trading.The Westford, Mass., company makes aesthetic treatment systems used to...

Compugen 4Q loss remains steady

February 15, 2011 10:45 am | by The Associated Press | Comments

Israeli drug developer Compugen Ltd. said Tuesday its fourth-quarter loss remained at $2 million even as spending increased.The company said it lost 6 cents per share, compare with a loss of $2 million, or 7 cents per share, during the same period a year prior. Compugen had about 4.7 million...

Advertisement

Genus Oncology, LLC Announces Initiation of Phase I Trial of GO-203-2c in Patients With Solid Tumors

February 15, 2011 10:34 am | by Bio-Medicine.Org | Comments

VERNON HILLS, Ill., Feb. 15, 2011 /- Genus Oncology, LLC, a clinical-stage company focused on commercializing novel drugs for treatment of cancer, announced it has successfully filed an Investigational New Drug (IND) application with the US Food & Drug Administration (FDA) and has...

TOPICS:

Mobile MIM, First FDA-Cleared Diagnostic Medical Imaging App, Now Available on the U.S. App Store

February 15, 2011 10:33 am | by Bio-Medicine.Org | Comments

CLEVELAND, Feb. 15, 2011 /- MIM Software Inc., a leading global provider of medical imaging software, announced today that Mobile MIM™ is available on the U.S. App Store. This news follows the FDA's announcement on February 4 that the app had received 510(k) clearance for remote...

TOPICS:

Alkermes says constipation drug met goal in study

February 15, 2011 9:45 am | by The Associated Press | Comments

Alkermes Inc. said Tuesday that a clinical trial shows one of its drug candidates can relieve constipation caused by use of opioid pain medications without reducing the effectiveness of the pain drugs.Alkermes said the two largest doses of its drug, which is designated ALKS 37, were both...

VisionScope stealthily lands $6.3M financing

February 15, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Stealthy medical device firm VisionScope Technologies LLC has raised $6.3 million in an equity offering, according to a regulatory filing.

AIKO Biotechnology steps back to reformulate, seek financing

February 15, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

AIKO Biotechnology Inc., a Portland, Maine, company focused on drug candidates to relieve the side effects from long-term prescription opioid pain reliever use, is taking a step back to reformulate its lead compound from an injectable into a pill.

Advertisement

Boston Scientific endowment recognizes Baim

February 15, 2011 7:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Boston Scientific Corp. said today that it has established a $1.7 million endowment for a scholarship fund at the Yale University School of Medicine in honor of the Boston Scientific chief medical and science officer Donald S. Baim, who died unexpectedly in 2009.

BIO study shows drug approval success rate slips

February 15, 2011 7:32 am | by Mass High Tech: The Journal of New England Technology | Comments

The Biotechnology Industry Organization (BIO) released a study Monday that shows a significant drop in the ratio of drugs moving through clinical studies and gaining U.S. Food and Drug Administration approval.

Endologix Announces Presentation of Favorable Initial PEVAR Trial Results

February 15, 2011 7:32 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., Feb. 15, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today the presentation of the initial clinical results from the PEVAR Trial at the 2011 iCON (International Congress of Endovascular Specialists)...

TOPICS:

Baxter Intl declares dividend, names officers

February 15, 2011 6:45 am | by The Associated Press | Comments

Drug and medical device maker Baxter International Inc. said Tuesday its board declared a quarterly dividend of 31 cents per share.The Deerfield, Ill., company said the dividend is payable April 1 to shareholders of record as of the close of business March 10.Baxter also said it named Chief...

United Therapeutics turns 4Q profit as sales grow

February 15, 2011 6:45 am | by The Associated Press | Comments

United Therapeutics Corp. said Tuesday it turned a fourth-quarter profit as revenue jumped 53 percent, led by growth from the biotechnology company's blood pressure treatments Remodulin and Tyvaso.The Silver Spring, Md., company earned $9.5 million, or 15 cents per share, in the three months...

First Medical-Grade Consumer Sleep Assessment Monitor Has Wristwatch Form-Factor And Uses Nordic 2.4ghz ANT Transceivers

February 15, 2011 6:42 am | Comments

The ReadiBandâ„¢ from Fatigue Science is the only consumer friendly, scientifically validated sleep assessment product to provide medical grade results without requiring users to stay overnight in a specialist sleep clinic.

TOPICS:

New Faces of Engineering 2011 Honors Brianne Maier

February 15, 2011 6:37 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., WASHINGTON, D.C., February 14, 2011 — They are the best of the best — the next generation of engineers whose innovation, leadership skills and commitment to excellence are helping to better our world and inspire young people to consider a career in...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading